Evidence map›Paper›PMID 14638771›Full record

ArticleInfection and immunity2003

Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies.

Victor C Hou, Gregory R Moe, Zyde Raad, Tomi Wuorimaa, Dan M Granoff

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review of meningococcal group B vaccines.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2010
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Victor C HouChildren's Hospital Oakland Research Institute, Oakland, California, USA.
Gregory R Moe
Zyde Raad
Tomi Wuorimaa
Dan M Granoff
Oaklands Hospital · GB

Funding

Novel vaccine strategies for prevention of N. meningitidis group B diseaseR01AI046464 · NIAID · OMVAX, INC. · PI MOE, GREGORY ROBERT · 2000 to 2024
$12.1M
MIMETICS OF CAPSULAR EPITOPES OF NEISSERIA MENINGITIDISR01AI045642 · NIAID · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI MOE, GREGORY R · 2000 to 2004
$2.9M
NIAID NIH HHS AI46464NIAID NIH HHS R01 AI045642NIAID NIH HHS R01 AI046464NIAID NIH HHS R01 AI45642
6 · The paper itself

Abstract

NspA is a conserved membrane protein that elicits protective antibody responses in mice against Neisseria meningitidis. A recent crystallographic study showed that NspA adopts an eight-stranded beta-barrel structure when reconstituted in detergent. In order to define the segments of NspA-containing epitopes recognized by protective murine anti-NspA antibodies, we studied the binding of two bactericidal and protective anti-NspA monoclonal antibodies (MAbs), AL12 and 14C7. Neither MAb binds to overlapping synthetic peptides (10-mers, 12-mers, and cyclic 12-mers) corresponding to the entire mature sequence of NspA, or to denatured recombinant NspA (rNspA), although binding to the protein can be restored by refolding in liposomes. Based on the ability of the two MAbs to bind to Escherichia coli microvesicles prepared from a set of rNspA variants created by site-specific mutagenesis, the most important contacts between the MAbs and NspA appear to be located within the LGG segment of loop 3. The conformation of loop 2 also appears to be an important determinant, as particular combinations of residues in this segment resulted in loss of antibody binding. Thus, the two anti-NspA MAbs recognize discontinuous conformational epitopes that result from the close proximity of loops 2 and 3 in the three-dimensional structure of NspA. The data suggest that optimally immunogenic vaccines using rNspA will require formulations that permit proper folding of the protein.

Indexed as

Protein ConformationAmino Acid SequenceAnimalsAntibodies, MonoclonalBacterial Outer Membrane ProteinsEpitopesHumansLiposomesMiceModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedNeisseria meningitidisProtein FoldingRatsRecombinant ProteinsAntibodies, MonoclonalBacterial Outer Membrane ProteinsEpitopesLiposomesNspA protein, NeisseriaRecombinant Proteins

Identifiers

PMID14638771
PMCPMC308938
OpenAlexW2107353241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.